Larry R. Solomon
- Molecular Biology top 10%
- Oncology top 10%
- Physiology top 10%
- Epidemiology
- Cell Biology top 10%
- Co-authors
- Karl A. WalterPeter A. RubensteinPhilip J. HajdukJohn E. HarlanPaul L. RichardsonEric F. JohnsonYan ShiEdward T. Olejniczak
- Topics
- PARP inhibition in cancer therapy (5 papers)DNA Repair Mechanisms (3 papers)Cell death mechanisms and regulation (3 papers)
- Cited by
- OncologyHepatologyMolecular Biology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Larry R. Solomon
34 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 1.0k
- Oncology 455
- Physiology 287
- Epidemiology 207
- Cell Biology 179
Countries citing papers authored by Larry R. Solomon
This map shows the geographic impact of Larry R. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry R. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry R. Solomon more than expected).
Fields of papers citing papers by Larry R. Solomon
This network shows the impact of papers produced by Larry R. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry R. Solomon. The network helps show where Larry R. Solomon may publish in the future.
Co-authorship network of co-authors of Larry R. Solomon
This figure shows the co-authorship network connecting the top 25 collaborators of Larry R. Solomon. A scholar is included among the top collaborators of Larry R. Solomon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry R. Solomon. Larry R. Solomon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | 126 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 198 | |
| 6 | 58 | |
| 7 | 139 | |
| 8 | 308 | |
| 9 | 13 | |
| 10 | 21 | |
| 11 | 56 | |
| 12 | 4 | |
| 13 | 5 | |
| 14 | 116 | |
| 15 | 13 | |
| 16 | 19 | |
| 17 | 4 | |
| 18 | 27 | |
| 19 | 9 | |
| 20 | 27 |
About Larry R. Solomon
Larry R. Solomon is a scholar working on Hepatology, Oncology and Music, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), DNA Repair Mechanisms (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Oncology (455 citations), Hepatology (127 citations) and Molecular Biology (1.0k citations). Larry R. Solomon has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Karl A. Walter, Peter A. Rubenstein, Philip J. Hajduk, John E. Harlan, Paul L. Richardson, Eric F. Johnson, Yan Shi, Edward T. Olejniczak, Thomas F. Holzman and David Maag. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.